Naason Science
Naason Science
  • Home
  • Research
    • Preclinical Research
    • CNS Models
    • Pain Models
    • Endometriosis Models
    • Oncology Models
    • Ophthalmology Models
    • Orthopedic Models
    • Metabolic Disease Models
    • Psychiatric Models
    • In Vitro
    • Safety & Toxicity Studies
  • News
  • Careers
    • Naason Team
    • Join the team
  • Investors
  • Contact
  • More
    • Home
    • Research
      • Preclinical Research
      • CNS Models
      • Pain Models
      • Endometriosis Models
      • Oncology Models
      • Ophthalmology Models
      • Orthopedic Models
      • Metabolic Disease Models
      • Psychiatric Models
      • In Vitro
      • Safety & Toxicity Studies
    • News
    • Careers
      • Naason Team
      • Join the team
    • Investors
    • Contact
  • Home
  • Research
    • Preclinical Research
    • CNS Models
    • Pain Models
    • Endometriosis Models
    • Oncology Models
    • Ophthalmology Models
    • Orthopedic Models
    • Metabolic Disease Models
    • Psychiatric Models
    • In Vitro
    • Safety & Toxicity Studies
  • News
  • Careers
    • Naason Team
    • Join the team
  • Investors
  • Contact

Psychiatric Disorders

Depression, Anxiety and PTSD

Naason Science models of PTSD in rat and minipig

PTSD is a serious anxiety disorder that can lead to intense fear and anxiety. Current medication is unspecific and ineffective, with a number of side effects. One limiting factor in the development of treatment for PTSD is the lack of valid, translational models. Naason Science has been developing models of PTSD in the rat and has initiated a development program in a larger animal - the minipig, based on a multi-faceted prolonged stress paradigm, so as to test the efficacy of new compounds. 


For more information please contact info@naasonscience.com 

Naason Science to be part of Consortium

Naason Science is part of a consortium for the development of a new potential treatment to reduce fear memory in post-traumatic stress disorder (PTSD).  By selectively targeting mGlu7 with NAMs, the brain circuitries involved in fear and anxiety can be precisely modulated, potentially resulting in higher efficacy and fewer side effects. 


Please find more information about the project here.

For more information please

Contact us

© 2023 Naason Science Inc. All rights reserved.

  • Home
  • Preclinical Research
  • News
  • Areas of Expertise
  • Privacy & Terms
  • Contact

Welcome to Naason Science website!

Our website uses cookies. By continuing to use this site, you accept our use of cookies.

DeclineAccept